FDA Grants Orphan Drug Designation to Bellicum’s BPX-501 for the Treatment of Immunodeficiency and GvHD Following Stem Cell Transplant http://finance.yahoo.com/news/fda-grants-orphan-drug-designation-120000607.html The start of the return to value. :)